Get started
Author

Nynke M. Kannegieter

Observed names: Kannegieter, N, Kannegieter, Nynke, N. Kannegieter, Nynke Kannegieter, Nynke M Kannegieter
ORCID: 0000-0003-2025-9426
Observed ORCID: 0000-0003-2025-9426
OpenAlex ID: A5013410049
Targeting the Monocyte–Macrophage Lineage in Solid Organ Transplantation
2017 · Thierry P. P. van den Bosch, Nynke M. Kannegieter, et al. · Frontiers in Immunology · 78
PDF
The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function
2017 · Nynke M. Kannegieter, Dennis A. Hesselink, et al. · PLoS ONE · 52
PDF
Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation
2016 · Carla C. Baan, Nynke M. Kannegieter, et al. · Transplantation · 34
Multiomics profiling of paired primary and recurrent glioblastoma patient tissues
2020 · Lennard J M Dekker, Nynke M Kannegieter, et al. · Neuro-Oncology Advances · 21
Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination
2015 · A.M.C.M. Doedée, N. Kannegieter, et al. · Vaccine · 19
pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients
2017 · Ling Huang, Nicolle H. R. Litjens, et al. · Immunity & Ageing · 18
PDF
Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel
2014 · B. ter Braak, C. L. E. Siezen, et al. · Archives of Toxicology · 18
Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients
2018 · Nynke M. Kannegieter, Dennis A. Hesselink, et al. · PLoS ONE · 13
Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial
2017 · Nynke M. Kannegieter, Dennis A. Hesselink, et al. · Scientific Reports · 13
PDF
Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation
2017 · Nynke M. Kannegieter, Dennis A. Hesselink, et al. · Therapeutic Drug Monitoring · 8
Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients
2015 · Nynke M. Kannegieter, Nauras Shuker, et al. · Therapeutic Drug Monitoring · 6
Innovative strategies for measuring kinase activity to accelerate the next wave of novel kinase inhibitors
2024 · Tim S. Veth, Nynke M. Kannegieter, et al. · Drug Discovery Today · 5
Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in glioblastoma
2022 · Federica Fabro, Nynke M. Kannegieter, et al. · Frontiers in Oncology · 4
Keystones in the implementation of greener pharmaceuticals: A scoping review
2025 · Ella D. van Vliet, Nynke M. Kannegieter, et al. · Sustainable Chemistry and Pharmacy · 3
Workshops en interviews over de regulatoire paraatheid voor meer duurzame geneesmiddelen tussen 2024 en 2030
2026 · Teresa Leonardo Alves, Nynke Kannegieter, et al. · Rivm (National Institute for Public Health and the Environment)
Workshop impact van PFAS restrictie op medische producten
2026 · Nynke Kannegieter, Ella van Vliet, et al. · Rivm (National Institute for Public Health and the Environment)
Tekortenbesluiten en het effect op de beschikbaarheid van geneesmiddelen
2026 · Kannegieter, N, van Vliet, E, et al. · Rivm (National Institute for Public Health and the Environment)
Single-Cell Analysis of NFATc1 Amplification in T Cells for Pharmacodynamic Monitoring of Tacrolimus
2018 · Nynke Kannegieter, Dennis Hesselink, et al. · Transplantation
Monitoring Signal Transduction after Kidney Transplantation
2018 · Nynke M. Kannegieter · EUR Research Repository (Erasmus University Rotterdam)
Additional file 1: Figure S1. of pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients
2017 · Huang, Ling, Litjens, Nicolle, et al. · Figshare
Works count: 22
Citation count: 292
H-index: 9
I10-index: 9
Year
Topic
Type